Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>

Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623 · see citing works

The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis

Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981 · see citing works

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595 · see citing works

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266 · see citing works

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164 · see citing works

Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993 · see citing works

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 974 · see citing works

The “Primary” Antiphospholipid Syndrome

Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963 · see citing works

The "primary" antiphospholipid syndrome: major clinical and serological features.

Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892 · see citing works

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., & Koike, T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91697-9 · Cited by 718 · see citing works

Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635 · see citing works

Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin

Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 575 · see citing works

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]

Oosting, J. D., Derksen, R. H. W. M., Bobbink, I. W. G., Hackeng, T. M., Bouma, B. N., & de Groot, P. G. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 487 · see citing works

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

Vaarala, O., Aho, K., Palosuo, T., Alfthan, G., Jauhiainen, M., & Leirisalo‐Repo, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91213-6 · Cited by 409 · see citing works

Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

Viard, J., Amoura, Z., & Bach, J. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90049-h · Cited by 266 · see citing works

β 2 -Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction

Brey, R. L., Abbott, R. D., Curb, J. D., Sharp, D. S., Ross, G. W., Stallworth, C. L., & Kittner, S. J. (2001) · Stroke · doi:10.1161/01.str.32.8.1701 · Cited by 250 · see citing works

Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus

Horbach, D. A., van Oort, E., Donders, R. C. J. M., Derksen, R. H. W. M., & de Groot, P. G. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650686 · Cited by 246 · see citing works

Heterogeneity in Meta-analysis of Data from Epidemiologic Studies: A Commentary

Colditz, G. A., Burdick, E., & Mosteller, F. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117644 · Cited by 245 · see citing works

Bias in meta-analytic research

Felson, D. T. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90072-u · Cited by 231 · see citing works

Anticardiolipin response in acute infections

Vaarala, O., Palosuo, T., Kleemola, M., & Aho, K. (1986) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(86)90046-2 · Cited by 231 · see citing works

Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.

Cabiedes, J., Cabral, A. R., & Alarcón-Segovia, D. (1995) · PubMed · Cited by 222 · see citing works

Development of an ELISA for Autoantibodies to Prothrombin Showing their Prevalence in Patients with Lupus Anticoagulants

Arvieux, J., Darnige, L., Caron, C., Reber, G., Bensa, J., & Colomb, M. G. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649891 · Cited by 210 · see citing works

Antibodies to β2‐glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

Tsutsumi, A., Matsuura, E., Ichikawa, K., Fujisaku, A., Mukai, M., Kobayashi, S., & Koike, T. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390905 · Cited by 192 · see citing works

Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome

Amengual, O. (1996) · British journal of rheumatology · doi:10.1093/rheumatology/35.12.1239 · Cited by 192 · see citing works

Different Anticoagulant and Immunological Properties of Anti-Prothrombin Antibodies in Patients with Antiphospholipid Antibodies

Galli, M., Beretta, G., Daldossi, M., Bevers, E. M., & Barbui, T. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655994 · Cited by 168 · see citing works

Anti β2 glycoprotein I antibodies: detection and association with thrombosis

Martinuzzo, M. E., Forastiero, R. R., & Carreras, L. O. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb03317.x · Cited by 163 · see citing works

Autoantibodies to Phospholipid-binding Plasma Proteins in Patients with Thrombosis and Phospholipid-reactive Antibodies

Pengo, V., Biasiolo, A., Brocco, T., Tonetto, S., & Ruffatti, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650355 · Cited by 159 · see citing works

Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?

Balestrieri, G., Tincani, A., Spatola, L., Allegri, F., Prati, E., Cattaneo, R., Valesini, G., Papa, N. D., & Meroni, P. L. (1995) · Lupus · doi:10.1177/096120339500400208 · Cited by 153 · see citing works

Antiprothrombin Antibodies: Detection and Clinical Significance in the Antiphospholipid Syndrome

Galli, M., & Barbui, T. (1999) · Blood · doi:10.1182/blood.v93.7.2149.407a33_2149_2157 · Cited by 151 · see citing works

Antiprothrombin Antibodies: Detection and Clinical Significance in the Antiphospholipid Syndrome

Galli, M., & Barbui, T. (1999) · Blood · doi:10.1182/blood.v93.7.2149 · Cited by 147 · see citing works

Relationship of Anti β2-giycoprotein I and Anti Prothrombin Antibodies to Thrombosis and Pregnancy Loss in Patients with Antiphospholipid Antibodies

Forastiero, R. R., Martinuzzo, M. E., Cerrato, G. S., Kordich, L., & Carreras, L. O. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657678 · Cited by 146 · see citing works

Anti‐annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody

Matsuda, J., Saitoh, N., Gohchi, K., Gotoh, M., & Tsukamoto, A. M. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470112 · Cited by 137 · see citing works

Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen- PE complex

Sugi, T., & McIntyre, J. (1995) · Blood · doi:10.1182/blood.v86.8.3083.3083 · Cited by 133 · see citing works

Antibodies to Prothrombin Imply a Risk of Myocardial Infarction in Middle-Aged Men

Vaarala, O., Puurunen, M. K., Mänttäri, M., Manninen, V., Aho, K., & Palosuo, T. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650296 · Cited by 130 · see citing works

Antiphospholipid Syndrome: Diagnostic Aspects of Lupus Anticoagulants

Arnout, J. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616204 · Cited by 121 · see citing works

Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.

Reber, G., Schousboe, I., Tincani, A., Sanmarco, M., Kveder, T., de Moerloose, P., Boffa, M., & Arvieux, J. (2002) · PubMed · Cited by 119 · see citing works

Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen- PE complex

Sugi, T., & McIntyre, J. (1995) · Blood · doi:10.1182/blood.v86.8.3083.bloodjournal8683083 · Cited by 119 · see citing works

Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.

Day, H. M., Thiagarajan, P., Ahn, C. W., Reveille, J. D., Tinker, K. F., & Arnett, F. C. (1998) · PubMed · Cited by 96 · see citing works

Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.

Cabral, A. R., Cabiedes, J., & Alarcón-Segovia, D. (1995) · PubMed · Cited by 95 · see citing works

The antiphospholipid syndrome II : autoimmune thrombosis

Asherson, R. A. (2002) · Cited by 91 · see citing works

Antibodies to β2-glycoprotein I—a specific marker for the antiphospholipid syndrome

Guerin, J., Feighery, C., Sim, R. B., & Jackson, J. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4601357.x · Cited by 91 · see citing works

Inter-laboratory Variability of Anti-β2-glycoprotein I Measurement

Schousboe, I., Tincani, A., Sanmarco, M., Kveder, T., de Moerloose, P., Boffa, M., Arvieux, J., & Reber, G. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613156 · Cited by 90 · see citing works

Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.

Bertolaccini, M. L., Atsumi, T., Khamashta, M. A., Amengual, O., & Hughes, G. R. V. (1998) · PubMed · Cited by 89 · see citing works

Comparison of an enzyme‐linked immunosorbent assay for antibodies to β2‐glycoprotein I and a conventional anticardiolipin immunoassay

Roubey, R. A. S., Maldonado, M. A., & Byrd, S. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390922 · Cited by 86 · see citing works

Antibodies to Phospholipid-Binding Plasma Proteins and Occurrence of Thrombosis in Patients with Systemic Lupus Erythematosus

Puurunen, M. K., Vaarala, O., Julkunen, H. A., Aho, K., & Palosuo, T. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0089 · Cited by 84 · see citing works

High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.

Palosuo, T., Virtamo, J. R. K., Haukka, J. K., Taylor, P. R., Aho, K., Puurunen, M. K., & Vaarala, O. (1997) · PubMed · Cited by 77 · see citing works

Untitled work

(1998) · PubMed · Cited by 75 · see citing works

High Antibody Levels to Prothrombin Imply a Risk of Deep Venous Thrombosis and Pulmonary Embolism in Middle-aged Men

Palosuo, T., Virtamo, J. R. K., Haukka, J. K., Taylor, P. R., Aho, K., Puurunen, M. K., & Vaarala, O. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657711 · Cited by 71 · see citing works

Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.

Swadźba, J., Clerck, L. S. D., Stevens, W. J., Bridts, C. H., Cotthem, K. A. V., Musiał, J., Jankowski, M., & Szczeklik, A. (1997) · PubMed · Cited by 71 · see citing works

Prevalence and clinical significance of IgG isotype anti-β2-glycoprotein I antibodies in antiphospholipid syndrome: A comparative study w

Sanmarco, M., Soler, C., Christides, C., Raoult, D., Weiller, P. J., Gérolami, V., & Bernard, D. J. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90004-4 · Cited by 67 · see citing works

Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar.

Santiago, M., Martinelli, R. P., Ko, A. I., Reis, E. A., Fontes, R. D., Nascimento, E. G., Pierangeli, S. S., Espinola, R. G., & Gharavi, A. E. (2001) · PubMed · Cited by 60 · see citing works

Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.

Lakos, G., Kiss, E. V., Regéczy, N., Tarján, P., Soltész, P., Zeher, M., Bodolay, E., Szűcs, G., Szakony, S., Sipka, S., et al. (2000) · PubMed · Cited by 60 · see citing works

Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.

Muñoz, F. J., Reverter, J. C., Font, J., Tàssies, D., Cervera, R., Espinosa, G., Carmona, F., Balasch, J., Ordinas, A., & Ingelmo, M. (2000) · PubMed · Cited by 56 · see citing works

Anti‐prothrombin antibodies combined with lupus anti‐coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus

Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Kitani, T., Iwatani, Y., & Kanakura, Y. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02950.x · Cited by 54 · see citing works

Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.

Bruce, I. N., Clark-Soloninka, C. A., Spitzer, K. A., Gladman, D. D., Urowitz, M. B., & Laskin, C. A. (2000) · PubMed · Cited by 52 · see citing works

Antibodies to Factor XII Associated with Lupus Anticoagulant

Gallimore, M. J., Harris, S. L., Winter, M., & Jones, D. W. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614483 · Cited by 51 · see citing works

Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia

Giordano, P., Galli, M., Vecchio, G., Altomare, M., Norbis, F., Ruggeri, L., Petronelli, M., & Mattia, D. D. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00853.x · Cited by 51 · see citing works

Factor VII/VIIa: a new antigen in the anti‐phospholipid antibody syndrome

Bidot, C., Jy, W., Horstman, L. L., Huisheng, H., Jimenez, J. J., Yaniz, M., & Ahn, Y. S. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04161.x · Cited by 51 · see citing works

Lupus Anticoagulants and Thrombosis: Clinical Association of Different Coagulation and Immunologic Tests

Dlott, J., Norbis, F., Ruggeri, L., Cler, L., Triplett, D., Barbui, T., & Galli, M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614164 · Cited by 48 · see citing works

Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.

Lee, S., Cho, M. L., Joo, Y.-S., Kim, W. U., Hong, Y. S., Min, J., Lee, S. H., Park, S. H., Cho, C. S., & Kim, H. (2001) · PubMed · Cited by 41 · see citing works

Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.

Martinuzzo, M. E., Pombo, G., Forastiero, R. R., Cerrato, G. S., Colorio, C. C., & Carreras, L. (1998) · PubMed · Cited by 39 · see citing works

Antibodies to tissue‐type plasminogen activator in plasma from patients with primary antiphospholipid syndrome

Cugno, M., Domínguez, M., Cabibbe, M., Bisiani, G., Galli, M., Anglés‐Cano, E., & Agostoni, A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01948.x · Cited by 39 · see citing works

Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism

Zanon, E., Prandoni, P., Vianello, F., Saggiorato, G., Carraro, G., Bagatella, P., & Girolami, A. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00105-x · Cited by 38 · see citing works

Anti‐prothrombin antibodies: assay conditions and clinical associations in the anti‐phospholipid syndrome

Donohoe, S., Mackie, I. J., Isenberg, D. A., & Machin, S. J. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02716.x · Cited by 38 · see citing works

Some Patients with Antiphospholipid Syndrome Express hitherto Undescribed Antibodies to Cardiolipin-binding Proteins

Rampazzo, P., Biasiolo, A., Garin, J., Rosato, A., Betterle, C., Ruffatti, A., & Pengo, V. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612904 · Cited by 34 · see citing works

A Cross Sectional Study of Antiphospholipid-protein Antibodies in Patients with Venous Thromboembolism

Amiral, J., Martin, L. D. S., Mottier, D., & Pasquier, É. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616083 · Cited by 25 · see citing works

Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibody syndrome.

Sorice, M., Pittoni, V., Circella, A., Misasi, R., Conti, F., Longo, A., Pontieri, G. M., & Valesini, G. (1998) · PubMed · Cited by 25 · see citing works

The Antiphospholipid Syndrome II

Bijl, M., & Kallenberg, C. G. M. (2002) · Elsevier eBooks · doi:10.1016/b978-0-444-50987-1.x5000-1 · Cited by 23 · see citing works

Anti-β2-Glycoprotein I and Anti-Prothrombin Antibodies in Antiphospholipid-Negative Patients with Thrombosis

Previtali, S., Barbui, T., & Galli, M. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613293 · Cited by 19 · see citing works

Is there a Role for Anti-phospholipid-binding Protein Antibodies in the Pathogenesis of Thrombosis in Behcet’s Disease?

Priori, R., Conti, F., Pittoni, V., Garofalo, T., Sorice, M., & Valesini, G. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613776 · Cited by 13 · see citing works

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]

Oosting, J., Derksen, R. H. W. M., Bobbink, I., et al. (1993) · Blood · doi:10.1182/blood.v81.10.2618.bloodjournal81102618 · Cited by 12 · see citing works

Antibodies to Cardiolipin and other Phospholipids

Pierangeli, S. S., & Harris, E. N. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50006-1 · Cited by 3 · see citing works

β2-glycoprotein-I and Anti-β2-glycoprotein-I Antibodies

de Groot, P. G., Bouma, B., Lutters, B. C. H., & Derksen, R. H. W. M. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50007-3 · Cited by 3 · see citing works

Untitled work

Wilson (1999) · doi:10.1002/1529-0131(199907)42:7

Untitled work

Atsumi (2000) · doi:10.1002/1529-0131(200009)43:9

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · see citing works

Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650 · see citing works

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306 · see citing works

Antiphospholipid syndrome

Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 864 · see citing works

Guidelines on the investigation and management of antiphospholipid syndrome

Keeling, D., Mackie, I., Moore, G. W., Greer, I. A., Greaves, M., & British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09037.x · Cited by 740 · see citing works

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

PENGO, V., RUFFATTI, A., LEGNANI, C., GRESELE, P., BARCELLONA, D., ERBA, N., TESTA, S., MARONGIU, F., BISON, E., DENAS, G., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03674.x · Cited by 633 · see citing works

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.52 · Cited by 620 · see citing works

Deep vein thrombosis

Kyrle, P. A., & Eichinger, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71880-8 · Cited by 620 · see citing works

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task Force at the 13th International Congress on antiphospholipid antibodies

Ruiz-Irastorza, G., Cuadrado, M., Ruiz-Arruza, I., Brey, R., Crowther, M., Derksen, R., Erkan, D., Krilis, S., Machin, S., Pengo, V, et al. (2011) · Lupus · doi:10.1177/0961203310395803 · Cited by 506 · see citing works

Management of Antiphospholipid Antibody Syndrome

Lim, W., Crowther, M. A., & Eikelboom, J. W. (2006) · JAMA · doi:10.1001/jama.295.9.1050 · Cited by 440 · see citing works

Antiphospholipid syndrome

Schreiber, K. I., Sciascia, S., de Groot, P. G., Devreese, K. M. J., Jacobsen, S., Ruiz‐Irastorza, G., Salmon, J. E., Shoenfeld, Y., Shovman, O., & Hunt, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.103 · Cited by 437 · see citing works

Antibody profiles for the diagnosis of antiphospholipid syndrome

Biasiolo, A., Pegoraro, C., Cucchini, U., Noventa, F., Iliceto, S., & Pengo, V. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0839 · Cited by 318 · see citing works

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

DE LAAT, B., PENGO, V., PABINGER, I., MUSIAL, J., VOSKUYL, A. E., BULTINK, I. E. M., RUFFATTI, A., ROZMAN, B., KVEDER, T., DE MOERLOOSE, P., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03588.x · Cited by 291 · see citing works

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

Rand, J. H., Wu, X.-X., Quinn, A. S., Ashton, A. W., Chen, P. P., Hathcock, J. J., Andree, H. A. M., & Taatjes, D. J. (2010) · Blood · doi:10.1182/blood-2009-04-213520 · Cited by 253 · see citing works

Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome

Sciascia, S., Sanna, G., Murru, V., Roccatello, D., Khamashta, M. A., & Bertolaccini, M. L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0509 · Cited by 253 · see citing works

β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome

de Laat, H. B., Derksen, R. H. W. M., Urbanus, R. T., Roest, M., & de Groot, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1107 · Cited by 219 · see citing works

Current concepts on the pathogenesis of the antiphospholipid syndrome

Giannakopoulos, B., Passam, F. H., Rahgozar, S., & Krilis, S. A. (2006) · Blood · doi:10.1182/blood-2006-04-001206 · Cited by 217 · see citing works

Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies

Zhang, J., & McCrae, K. R. (2004) · Blood · doi:10.1182/blood-2004-05-1708 · Cited by 212 · see citing works

Lupus anticoagulants and the risk of a first episode of deep venous thrombosis

DE GROOT, P. G., LUTTERS, B., DERKSEN, R. H. W. M., LISMAN, T., MEIJERS, J. C. M., & ROSENDAAL, F. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01485.x · Cited by 205 · see citing works

The antiphospholipid syndrome in patients with systemic lupus erythematosus

Pons‐Estel, G., Andréoli, L., Scanzi, F., Cervera, R., & Tincani, A. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.10.004 · Cited by 203 · see citing works

Antiphospholipid antibodies promote leukocyte–endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2

Ramesh, S., Morrell, C. N., Tarango, C., Thomas, G. D., Yuhanna, I. S., Girardi, G., Herz, J., Urbanus, R. T., de Groot, P. G., Thorpe, P. E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39828 · Cited by 195 · see citing works

How we diagnose the antiphospholipid syndrome

Giannakopoulos, B., Passam, F. H., Ioannou, Y., & Krilis, S. A. (2008) · Blood · doi:10.1182/blood-2007-12-129627 · Cited by 186 · see citing works

Prevention and Treatment of Venous Thromboembolism

Nicolaides, A. N., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R. D., Myers, K. A., Samama, M. M., Fletcher, J., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840 · Cited by 186 · see citing works

The geoepidemiology of the antiphospholipid antibody syndrome

Biggioggero, M., & Meroni, P. L. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.11.013 · Cited by 185 · see citing works

Antiphospholipid Syndrome

Corban, M., Duarte‐García, A., McBane, R. D., Matteson, E. L., Lerman, L. O., & Lerman, A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.058 · Cited by 182 · see citing works

Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis

Reynaud, Q., Lega, J.-C., Mismetti, P., Chapelle, C., Wahl, D., Cathébras, P., & Laporte, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.004 · Cited by 179 · see citing works

‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

Pierangeli, S., de Groot, P. G., Dlott, J. S., Favaloro, E. J., Harris, E., Lakos, G., Ortel, T. L., Meroni, P. L., Otomo, K., Pengo, V., et al. (2011) · Lupus · doi:10.1177/0961203310395055 · Cited by 179 · see citing works

Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome

Cesarman-Maus, G. N., Ríos-Luna, N. P., Deora, A. B., Huang, B., Villa, R., Cravioto, M. D. C., Alarcón-Segovia, D., Sánchez‐Guerrero, J., & Hajjar, K. A. (2006) · Blood · doi:10.1182/blood-2005-07-2636 · Cited by 174 · see citing works

Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study

Galli, M., Borrelli, G., Jacobsen, E. M., Marfisi, R. M., Finazzi, G., Marchioli, R., Wisloff, F., Marziali, S., Morboeuf, O., & Barbui, T. (2007) · Blood · doi:10.1182/blood-2007-01-066043 · Cited by 170 · see citing works

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

FORASTIERO, R., MARTINUZZO, M., POMBO, G., PUENTE, D., ROSSI, A., CELEBRIN, L., BONACCORSO, S., & AVERSA, L. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01295.x · Cited by 170 · see citing works

The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review

Sciascia, S., Sanna, G., Khamashta, M. A., Cuadrado, M. J., Erkan, D., Andréoli, L., & Bertolaccini, M. L. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205663 · Cited by 162 · see citing works

The potential role of heparin in assisted conception

Nelson, S. M., & Greer, I. A. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn031 · Cited by 160 · see citing works

‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

Bertolaccini, M. L., Amengual, O., Atsumi, T., Binder, W., de Laat, B., Forastiero, R. R., Kutteh, W. H., Lambert, M., Matsubayashi, H., Murthy, V. L., et al. (2011) · Lupus · doi:10.1177/0961203310397082 · Cited by 148 · see citing works

β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model

Arad, A., Proulle, V., Furie, R. A., Furie, B. C., & Furie, B. (2011) · Blood · doi:10.1182/blood-2010-08-300715 · Cited by 140 · see citing works

Pathophysiology of the antiphospholipid syndrome

de Groot, P. G., & Derksen, R. H. W. M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01359.x · Cited by 134 · see citing works

Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies

Tincani, A., Allegri, F., Balestrieri, G., Reber, G., Sanmarco, M., Meroni, P. L., & Boffa, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.035 · Cited by 128 · see citing works

Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review

Sciascia, S., Bertolaccini, M. L., Roccatello, D., Khamashta, M. A., & Sanna, G. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7406-8 · Cited by 114 · see citing works

Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)

Andrade, R. M., Alarcón, G. S., González, L., Fernández, M., Apte, M., Vilá, L. M., McGwin, G., & Reveille, J. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.077594 · Cited by 114 · see citing works

Antiprothrombin antibodies detected in two different assay systems

Atsumi, T., Koike, T., Hughes, G. R. V., Khamashta, M. A., & Bertolaccini, M. L. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-06-0382 · Cited by 113 · see citing works

Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events

Feinbloom, D. B., & Bauer, K. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181762.31694.da · Cited by 112 · see citing works

Antiphospholipid Syndrome during pregnancy: the state of the art.

Prima, F. A. F. D., Valenti, O., Hyseni, E., Giorgio, E., Faraci, M., Renda, E., Domenico, R. D., & Monte, S. (2011) · PubMed Central · Cited by 111 · see citing works

Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study

Gris, J., Bouvier, S., Molinari, N., Galanaud, J. ‐., Cochery-Nouvellon, É., Mercier, É., Fabbro-Péray, P., Balducchi, J.-P., Marès, P., Quéré, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-381913 · Cited by 108 · see citing works

Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus

Male, C., Foulon, D., Hoogendoorn, H., Vegh, P., Silverman, E., David, M., & Mitchell, L. (2005) · Blood · doi:10.1182/blood-2005-05-2048 · Cited by 106 · see citing works

The annexin A2 system and vascular homeostasis

Flood, E. C., & Hajjar, K. A. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.03.003 · Cited by 103 · see citing works

Antiphospholipid syndrome; its implication in cardiovascular diseases: a review

Koniari, I. C., Siminelakis, S. N., Baikoussis, N. G., Papadopoulos, G., Goudevenos, J. A., & Apostolakis, E. E. (2010) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-5-101 · Cited by 103 · see citing works

Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope

de Laat, B., van Berkel, M., Urbanus, R. T., Siregar, B., de Groot, P. G., Gebbink, M. F. B. G., & Maas, C. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30633 · Cited by 103 · see citing works

Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants

Nakashima, M. O., & Rogers, H. J. (2014) · Blood Research · doi:10.5045/br.2014.49.2.85 · Cited by 101 · see citing works

Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome

Woller, S. C., Stevens, S. M., Kaplan, D. A., Branch, D. W., Aston, V. T., Wilson, E. L., Gallo, H. M., Johnson, E., Rondina, M. T., Lloyd, J. F., et al. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615615960 · Cited by 99 · see citing works

High titer of anti–phosphatidylserine‐prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa

Kawakami, T., Yamazaki, M., Mizoguchi, M., & Soma, Y. (2007) · Arthritis Care & Research · doi:10.1002/art.23081 · Cited by 93 · see citing works

Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases

Meroni, P. L., Biggioggero, M., Pierangeli, S. S., Sheldon, J., Zegers, I., & Borghi, M. O. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.180 · Cited by 92 · see citing works

Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanism

de Laat, B., Mertens, K., & de Groot, P. G. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0740 · Cited by 90 · see citing works

Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies

Forastiero, R. R., Martinuzzo, M. E., & Larrañaga, G. F. D. (2005) · Lupus · doi:10.1191/0961203305lu2048oa · Cited by 89 · see citing works

The antiphospholipid syndrome and heart valve surgery

Gorki, H., Malinovski, V., & Stanbridge, R. D. L. (2007) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.11.004 · Cited by 88 · see citing works

Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria

Litvinova, E., Darnige, L., Kirilovsky, A., Burnel, Y., Luna, G. D., & Dragon‐Durey, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02971 · Cited by 87 · see citing works

Invitation to a debate on the serological criteria that define the antiphospholipid syndrome

GALLI, M., REBER, G., DE MOERLOOSE, P., & DE GROOT, P. G. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02862.x · Cited by 85 · see citing works

The presence of IgG antibodies against β2‐glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant

Rintelen, C., Vormittag, R., Sailer, T., Lehr, S., Quehenberger, P., Rumpold, H., Male, C., & Pabinger, I. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01394.x · Cited by 82 · see citing works

Anti‐prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15‐year longitudinal study

Bizzaro, N., Ghirardello, A., Zampieri, S., Iaccarino, L., Tozzoli, R., Ruffatti, A., Villalta, D., Tonutti, E., & Doria, A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02532.x · Cited by 81 · see citing works

Laboratory Testing for Lupus Anticoagulants: A Review of Issues Affecting Results

Tripodi, A. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.089524 · Cited by 81 · see citing works

Anti‐beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women

Meroni, P. L., Peyvandi, F., Foco, L., Bernardinelli, L., Fetiveau, R., Mannucci, P. M., & Tincani, A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02763.x · Cited by 77 · see citing works

Antiphospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-β2-Glycoprotein I activity

Pengo, V., Biasiolo, A., Bison, E., Chantarangkul, V., & Tripodi, A. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.07.014 · Cited by 77 · see citing works

Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome

Urbanus, R. T., Derksen, R. H. W. M., & de Groot, P. G. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.09.001 · Cited by 76 · see citing works

Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis

Santos, T. D. S., Ieque, A. L., de Carvalho, H. C., Sell, A. M., Lonardoni, M. V. C., Demarchi, I. G., Neto, Q. A. D. L., & Teixeira, J. J. V. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.09.007 · Cited by 76 · see citing works

Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines

Favaloro, E. J., & Wong, R. C. W. (2014) · Pathology · doi:10.1097/pat.0000000000000142 · Cited by 75 · see citing works

Autoantibodies in Nonautoimmune Individuals during Infections

Berlin, T., Zandman‐Goddard, G., Blank, M., Matthias, T., Pfeiffer, S., Weis, I., Toubi, E., Singh, S., Asherson, R. A., Fraser, A., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.061 · Cited by 74 · see citing works

β2-Glycoprotein I, the playmaker of the antiphospholipid syndrome

de Laat, H. B., Derksen, R. H. W. M., & de Groot, P. G. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.012 · Cited by 70 · see citing works

Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review

Radin, M., Cecchi, I., Roccatello, D., Meroni, P. L., & Sciascia, S. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1603936 · Cited by 68 · see citing works

Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant

Sciascia, S., Murru, V., Garcia-Fernandez, C., Sanna, G., Khamashta, M., & Bertolaccini, M. L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0527 · Cited by 67 · see citing works

Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid Syndrome

Vlagea, A. D., Gil, A., Cuesta‐Corral, M., Arribas, F., Diez, J., Lavilla, P., & Pascual‐Salcedo, D. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612437578 · Cited by 66 · see citing works

Antiphospholipid antibodies in lymphoma: prevalence and clinical significance

Pusterla, S., Previtali, S., Marziali, S., Cortelazzo, S., Rossi, A., Barbui, T., & Galli, M. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200377 · Cited by 66 · see citing works

The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies

Nash, M. J., Camilleri, R. S., Kunka, S., Mackie, I. J., Machin, S. J., & Cohen, H. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00810.x · Cited by 64 · see citing works

Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder

D’Ippolito, S., Meroni, P. L., Koike, T., Veglia, M., Scambia, G., & Simone, N. D. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.05.004 · Cited by 64 · see citing works

Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study

Amengual, O., Forastiero, R. R., Sugiura‐Ogasawara, M., Otomo, K., Oku, K., Favas, C., Alves, J. D., Žigon, P., Ambrožič, A., Tomšič, M., et al. (2016) · Lupus · doi:10.1177/0961203316660203 · Cited by 63 · see citing works

Antiphospholipid syndrome

Khamashta, M. A., Taraborelli, M., Sciascia, S., & Tincani, A. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.04.002 · Cited by 62 · see citing works

Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?

Pregnolato, F., Chighizola, C. B., Encabo, S., Shums, Z., Norman, G. L., Tripodi, A., Chantarangkul, V., Bertero, T., Micheli, V. D., Borghi, M. O., et al. (2013) · Immunologic Research · doi:10.1007/s12026-013-8421-z · Cited by 61 · see citing works

Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study

Comellas-Kirkerup, L., Hernández‐Molina, G., & Cabral, A. R. (2010) · Blood · doi:10.1182/blood-2010-05-283507 · Cited by 61 · see citing works

The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature

Chighizola, C. B., Andréoli, L., de Jesús, G. R., Banzato, A., Pons‐Estel, G., & Erkan, D. (2015) · Lupus · doi:10.1177/0961203315572714 · Cited by 59 · see citing works

Variability of anti-β2 glycoprotein I antibodies measurement by commercial assays

Tincani, A., Sanmarco, M., de Moerloose, P., Boffa, M., & Reber, G. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-02-0081 · Cited by 59 · see citing works

Cofactor‐independent human antiphospholipid antibodies induce venous thrombosis in mice

Manukyan, D., Müller‐Calleja, N., Jäckel, S., Luchmann, K., Mönnikes, R., Kiouptsi, K., Reinhardt, C., Jurk, K., Walter, U., & Lackner, K. J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13263 · Cited by 58 · see citing works

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes

Brenner, B. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00504.x · Cited by 58 · see citing works

Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2′ and glycoprotein I bα

Zhang, W., Gao, F., Lu, D., Sun, N., Yin, X., Jin, M., & Liu, Y. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0426-7 · Cited by 56 · see citing works

Risk factors for arterial thrombosis in antiphospholipid syndrome

Matyja‐Bednarczyk, A., Swadźba, J., Iwaniec, T., Sanak, M., Dziedzina, S., Ćmiel, A., & Musiał, J. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.11.012 · Cited by 54 · see citing works

Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies

Chauleur, C., Galanaud, J. ‐., Alonso, S., Cochery-Nouvellon, É., Balducchi, J.-P., Marès, P., Fabbro-Péray, P., & Gris, J. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03747.x · Cited by 54 · see citing works

Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case–control study

Martínez‐Zamora, M. Á., Peralta, S., Creus, M. T., Tàssies, D., Reverter, J. C., Espinosa, G., Cervera, R., Carmona, F., & Balasch, J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.153817 · Cited by 54 · see citing works

Risk of venous thromboembolism in autoimmune diseases: A comprehensive review

Menichelli, D., Cormaci, V. M., Marucci, S., Franchino, G., Sole, F. D., Capozza, A., Fallarino, A., Valeriani, E., Violi, F., Pignatelli, P., et al. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103447 · Cited by 52 · see citing works

Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome

Fujieda, Y., Atsumi, T., Amengual, O., Odani, T., Otomo, K., Kato, M., Oku, K., Kon, Y., Horita, T., Yasuda, S., et al. (2012) · Lupus · doi:10.1177/0961203312458469 · Cited by 52 · see citing works

Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients

Ma, J., Song, H., Wei, M., & He, Y. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3776-5 · Cited by 51 · see citing works

Antiphospholipid antibodies: Lessons from the bench

Koike, T., Bohgaki, M., Amengual, O., & Atsumi, T. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.009 · Cited by 51 · see citing works

Obstetric and vascular APS: Same autoantibodies but different diseases?

Meroni, P. L., Raschi, E., Grossi, C., Pregnolato, F., Trespìdi, L., Acaia, B., & Borghi, M. O. (2012) · Lupus · doi:10.1177/0961203312438116 · Cited by 50 · see citing works

The Lupus Anticoagulant Paradox

Molhoek, J. E., de Groot, P. G., & Urbanus, R. T. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1606190 · Cited by 50 · see citing works

Annexin A2: biology and relevance to the antiphospholipid syndrome

Cockrell, E., Espinola, R., & McCrae, K. (2008) · Lupus · doi:10.1177/0961203308095329 · Cited by 50 · see citing works

High titer of serum antiphospholipid antibody levels in adult Henoch‐Schönlein purpura and cutaneous leukocytoclastic angiitis

Kawakami, T., Yamazaki, M., Mizoguchi, M., & Soma, Y. (2008) · Arthritis Care & Research · doi:10.1002/art.23528 · Cited by 50 · see citing works

The obstetric antiphospholipid syndrome

Derksen, R. H. W. M., & de Groot, P. G. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2006.12.003 · Cited by 50 · see citing works

Internal quality control and external quality assurance in testing for antiphospholipid antibodies: part II–lupus anticoagulant

Favaloro, E., Bonar, R., & Marsden, K. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1311993 · Cited by 49 · see citing works

Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts

Capozzi, A., Manganelli, V., Riitano, G., Caissutti, D., Longo, A., Garofalo, T., Sorice, M., & Misasi, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030891 · Cited by 49 · see citing works

An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies

de Laat, B., Derksen, R. H. W. M., Reber, G., Musiał, J., Swadźba, J., Božič, B., Čučnik, S., Regnault, V., Forastiero, R. R., Woodhams, B. J., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04068.x · Cited by 49 · see citing works

Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies

Choojitarom, K., Verasertniyom, O., Totemchokchyakarn, K., Nantiruj, K., Sumethkul, V., & Janwityanujit, S. (2007) · Clinical Rheumatology · doi:10.1007/s10067-007-0721-z · Cited by 49 · see citing works

Clinical laboratory testing for the antiphospholipid syndrome

Pierangeli, S. S., & Harris, E. N. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.002 · Cited by 49 · see citing works

Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses

Christiansen, O. B., Nielsen, H. S., Lund, M., Steffensen, R., & Varming, K. (2008) · Human Reproduction · doi:10.1093/humrep/den377 · Cited by 48 · see citing works

Thrombophilia and Pregnancy

Kupferminc, M. J. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381855 · Cited by 47 · see citing works

Anti‐prothrombin IgG from patients with anti‐phospholipid antibodies inhibits the inactivation of factor Va by activated protein C

Galli, M., Willems, G. M., Rosing, J., Janssen, R. M., Govers‐Riemslag, J. W. P., Comfurius, P., Barbui, T., Zwaal, R. F. A., & Bevers, E. M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05438.x · Cited by 47 · see citing works

Antiphospholipid antibodies and thrombosis: strength of association

Galli, M., & Barbui, T. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200206 · Cited by 61 · see citing works

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

FORASTIERO, R., MARTINUZZO, M., POMBO, G., PUENTE, D., ROSSI, A., CELEBRIN, L., BONACCORSO, S., & AVERSA, L. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01295.x · Cited by 170 · see citing works

Antiphospholipid Syndrome: Association Between Laboratory Tests and Clinical Practice

Galli, M. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083810 · Cited by 23 · see citing works

Antiphospholipid antibodies in systemic lupus erythematosus and the antiphospholipid syndrome

Yatish, N. S. (2001) · Frontiers in bioscience · doi:10.2741/setty · Cited by 8 · see citing works

Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome

de Groot, P. G., & de Laat, B. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.008 · Cited by 62 · see citing works